Avelumab: Phase II data

Top-line data from 61 evaluable patients with metastatic MCC that has progressed following chemotherapy and who were followed for

Read the full 197 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE